According to IMARC Group’s latest report, titled “Angioplasty Balloons Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global angioplasty balloons market size reached US$ 2.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2027, exhibiting a growth rate (CAGR) of 3.4% during 2022-2027.
Angioplasty balloons are medical devices used to open narrowed or blocked arteries during surgical interventions. They are balloon-tipped catheters used to flatten the plaque against the artery wall during an angioplasty procedure. Drug-eluting, normal, scoring, and cutting are some standard angioplasty balloons. They are manufactured using polyethylene terephthalate (PET), nylon, and silicone urethane polymers. They consist of nitinol-constraining structures that create pillows and grooves on the surface of the balloon to offer a uniform, predictable, and atraumatic dilation. As a result, angioplasty balloons are extensively used in coronary and peripheral angioplasty surgeries.
Request for a Free PDF sample report: https://www.imarcgroup.com/angioplasty-balloons-market/requestsample
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Angioplasty Balloons Market Trends:
The rising geriatric population suffering from lifestyle diseases, such as atherosclerosis and heart failure, is creating a positive outlook for the market. In line with this, the increasing prevalence of coronary and peripheral artery diseases, especially amongst millennials, is also acting as a growth-inducing factor. Angioplasty balloons are widely used in minimally invasive surgeries (MIS) that reduce scarring, surgical pain, and hospital stay, offer higher accuracy, and promote faster recovery. Moreover, the widespread adoption of angioplasty balloons over traditional angioplasty techniques and utilization of vessel implants, such as stents, as they have superior safety and improved blood flow throughout the body, is propelling the market growth. Other factors, including rising consumer health consciousness, significant expansion in the healthcare infrastructure, and extensive research and development (R&D) activities in medical science, are supporting the market growth.
Competitive Landscape with Key Players:
The report has also analysed the competitive landscape of the market with some of the key players.
- Abbott Laboratories
- Braun Melsungen AG
- BD (Becton, Dickinson, and Company)
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Endocor GmbH & Co. KG
- Johnson & Johnson
- Medtronic Inc.
- Terumo Corporation
Key Market Segmentation:
The report has categorized the market based on product type, application, material and end-user.
Breakup by Product Type:
- Normal Balloons
- Cutting Balloons
- Drug Eluting Balloons
- Scoring Balloons
Breakup by Application:
- Coronary Angioplasty
- Peripheral Angioplasty
Breakup by Material:
- Nylon
- Polyurethane
- Silicone Urethane Co-Polymers
- Others
Breakup by End-User:
- Hospitals
- Ambulatory Surgery Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
